Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis

Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis

<p>Abstract</p> <p>Corticosteroids are standard treatment for patients with multiple sclerosis experiencing acute relapse. Because dyspeptic pain is a common side effect of this intervention, patients can be given a histamine receptor-2 antagonist, proton pump inhibitor or antacid...

Full description

Bibliographic Details
Main Authors:	Biswas Sangita, Benedict Stephen H, Lynch Sharon G, LeVine Steven M
Format:	Article
Language:	English
Published:	BMC 2012-06-01
Series:	BMC Medicine
Subjects:	Antacid autoimmune dyspepsia experimental autoimmune encephalomyelitis GERD histamine receptor 2 antagonists multiple sclerosis proton pump inhibitor
Online Access:	http://www.biomedcentral.com/1741-7015/10/57

Similar Items

HISTORICAL PERSPECTIVE OF GASTROESOPHAGEAL REFLUX DISEASE CLINICAL TREATMENT
by: Schlioma ZATERKA, et al.

Nature plus Nurture*: the triggering of multiple sclerosis
by: Hartmut Wekerle
Published: (2015-09-01)

The Role of Selected Interleukins in the Development and Progression of Multiple Sclerosis—A Systematic Review
by: Cezary Grunwald, et al.
Published: (2024-02-01)

Neuroprotection in an Experimental Model of Multiple Sclerosis via Opening of Big Conductance, Calcium-Activated Potassium Channels
by: Gareth Pryce, et al.
Published: (2023-07-01)

The Role of MicroRNAs in Repair Processes in Multiple Sclerosis
by: Conor P. Duffy, et al.
Published: (2020-07-01)

Emerging strategies for treating autoimmune disorders in patients with type 1 diabetes and multiple sclerosis
by: P.P. Kravchun, et al.
Published: (2023-10-01)

B cells in multiple sclerosis
by: Hartmut Wekerle
Published: (2017-01-01)

Toward a Combination of Biomarkers for Molecular Characterization of Multiple Sclerosis
by: Dafni Birmpili, et al.
Published: (2022-11-01)

Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells
by: Maryam J. Tavaf, et al.
Published: (2023-01-01)

The Anti-inflammatory Effect of Ginger Extract on the Animal Model of Multiple Sclerosis
by: Fatemeh Kamankesh, et al.
Published: (2023-06-01)

A role for cathepsin Z in neuroinflammation provides mechanistic support for an epigenetic risk factor in multiple sclerosis
by: Euan R. O. Allan, et al.
Published: (2017-05-01)

Influence of generics in prescribing dynamics of proton pump inhibitors in general practice
by: Simona Cammarota, et al.
Published: (2009-03-01)

Targeting Voltage-Dependent Calcium Channels with Pregabalin Exerts a Direct Neuroprotective Effect in an Animal Model of Multiple Sclerosis
by: Petra Hundehege, et al.
Published: (2018-11-01)

Immune Thymic Profile of the MOG-Induced Experimental Autoimmune Encephalomyelitis Mouse Model
by: Sofia P. das Neves, et al.
Published: (2018-10-01)

Allopregnanolone and Neuroinflammation: a Focus on Multiple Sclerosis
by: Farshid eNoorbakhsh, et al.
Published: (2014-06-01)

Indomethacin-induced gastric ulceration in rats: Protective roles of Spondias mombin and Ficus exasperata
by: Saheed Sabiu, et al.
Published: (2015-01-01)

Prediction of Ventilator-Associated Pneumonia in Patients Undergoing Stress Ulcer Prophylaxis: A Longitudinal Descriptive Study in Iran
by: Shahriar Nikpour, et al.
Published: (2020-11-01)

Comparison of Acid-neutralizing capacity of antacids in Erbil City
by: Dina Aziz Boya, et al.
Published: (2021-08-01)

Curcumin ameliorates oxidative stress in animal models of multiple sclerosis
by: Laleh Mavaddatiyan, et al.
Published: (2019-04-01)

Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis
by: Polak Paul E, et al.
Published: (2012-12-01)

Effects of Quercetin on Improving the Damage Caused by Free Radicals in the Rat Models of Multiple Sclerosis
by: Elina Mirzazadeh, et al.
Published: (2019-04-01)

The Effects of Nicotine on the Stimulation of the Cholinergic System and Immune Responses Changes in Animal Models of Multiple Sclerosis
by: M Shahmoradi, et al.
Published: (2016-06-01)

Functional relevance of the multi-drug transporter abcg2 on teriflunomide therapy in an animal model of multiple sclerosis
by: Lisa Thiele née Schrewe, et al.
Published: (2020-01-01)

Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis
by: Jordan R. Warford, et al.
Published: (2018-01-01)

Association of New Putative Epitopes of Myelin Proteolipid Protein (58-74) with Pathogenesis of Multiple Sclerosis
by: Zahra Zamanzadeh, et al.
Published: (2016-10-01)

History and Pharmacological Mechanism of Gastric Acid-suppressive Drugs
by: Dong Han Yeom, et al.
Published: (2023-09-01)

Oligodendrocyte-specific Argonaute profiling identifies microRNAs associated with experimental autoimmune encephalomyelitis
by: Qin Ma, et al.
Published: (2020-10-01)

Organic Selenium Reaches the Central Nervous System and Downmodulates Local Inflammation: A Complementary Therapy for Multiple Sclerosis?
by: Juliana Helena dos Santos de Toledo, et al.
Published: (2020-10-01)

Effect of Cordyceps sinensis on the Treatment of Experimental Autoimmune Encephalomyelitis: A Pilot Study on Mice Model
by: Shan-Shan Zhong, et al.
Published: (2017-01-01)

Potassium-competitive acid blockers, a new therapeutic class, and their role in acid-related diseases: a narrative review
by: Gerson Domingues, et al.
Published: (2022-08-01)

COMPARISON OF THE EFFICACIES OF PROTON PUMP INHIBITORS AND H2 RECEPTOR ANTAGONISTS IN ON-DEMAND TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE
by: Nesibe Vardı, et al.
Published: (2018-08-01)

The brain cytokine orchestra in multiple sclerosis: from neuroinflammation to synaptopathology
by: Roberta Amoriello, et al.
Published: (2024-01-01)

Multiple sclerosis and exercise—A disease-modifying intervention of mice or men?
by: Sarah-Jane Martin, et al.
Published: (2023-10-01)

Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis
by: Javier Marín-Prida, et al.
Published: (2022-11-01)

Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions
by: Alessandra Musella, et al.
Published: (2018-08-01)

RhoA Drives T-Cell Activation and Encephalitogenic Potential in an Animal Model of Multiple Sclerosis
by: Alba Manresa-Arraut, et al.
Published: (2018-05-01)

Editorial: Diet and multiple sclerosis
by: Tyler J. Titcomb, et al.
Published: (2023-12-01)

Deubiquitinating enzymes (DUBs): DoUBle-edged swords in CNS autoimmunity
by: Jing Ruan, et al.
Published: (2020-04-01)

High-Intensity Exercise Training Protects the Brain Against Autoimmune Neuroinflammation: Regulation of Microglial Redox and Pro-inflammatory Functions
by: Yifat Zaychik, et al.
Published: (2021-02-01)

Current Perspectives: Evidence to Date on BTK Inhibitors in the Management of Multiple Sclerosis
by: Carnero Contentti E, et al.
Published: (2022-10-01)